Chimera Biotec provides ultra sensitive GLP/GCP bioanalytical support for all phases of drug development and non-regulated rapid discovery phase research. Building upon our proprietary Immuno-PCR technology, Imperacer®, our scientific team has gained extensive experience in the development and validation of ultra sensitive immunoassays. Starting with our custom assay development or assay transfer on your preferred platform, take advantage of our strong scientific background and technical services - conducted under the strict quality regime.

More about our services



Chimera Biotec provides ultra sensitive GLP/GCP bioanalytical support for all phases of drug discovery and development. For over 20 years, we have specialized in supporting drug development programs with highest demands on bioanalytical quality. Our long standing know how in beyond ELISA sensitive immunoassays enables us to make the most out of any immunoassay platform.

More about our expertise


Chimera Biotec has the longest track record in ultra sensitive ligand binding assays in the industry. We provide premium services and state of the art solutions to tackle your most challenging study support with our vast experience in state-of-the art immunoassay platforms. In our GLP / GCP certified bioanalytical laboratory we use our outstanding expertise in beyond ELISA sensitivities in sub-pg/ml concentrations to fulfill sensitivity needs and regulatory demands.

More about our technologies

Upcoming Events

March 30 - April 3, 2020

Phoenix / USA

Read more

May 29 - June 2, 2020

Chicago, IL / USA

Read more


to support ultra sensitive efficacy testing of an oral and nasal vaccine delivery platform with low volume mucosal tissue samples

Read more

The German national cohort (NAKO) conducts a long-term study “Joint Research for a Healthier Future” for prevention and early diagnosis of prevalent…

Read more